NasdaqCM - Nasdaq Real Time Price USD
OKYO Pharma Limited (OKYO)
1.3400
-0.0900
(-6.29%)
At close: May 14 at 4:00:00 PM EDT
1.3600
0.00
(0.00%)
After hours: May 14 at 4:05:09 PM EDT
Breakdown
TTM
3/31/2024
3/31/2023
3/31/2022
3/31/2021
Operating Cash Flow
-9,490.5370
-9,490.5370
-7,695.2420
-5,468.0650
-1,600.1980
Investing Cash Flow
0
0
-5.9160
-1.6690
-18.1140
Financing Cash Flow
6,208.5080
6,208.5080
9,323.3540
2,153.2700
7,826.9380
End Cash Position
826.8480
826.8480
4,045.3810
2,700.7240
6,889.3290
Capital Expenditure
--
--
-5.9160
-1.6690
-6.9430
Issuance of Capital Stock
6,208.5080
6,208.5080
7,323.3540
0
230.0190
Issuance of Debt
0
0
2,000
0
7,593.3800
Repayment of Debt
--
--
0
0
-12.3310
Free Cash Flow
-9,490.5370
-9,490.5370
-7,701.1580
-5,469.7340
-1,607.1410
3/31/2021 - 5/17/2022
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
IVA Inventiva S.A.
3.5007
-0.26%
ELTX Elicio Therapeutics, Inc.
5.41
-5.25%
OCS Oculis Holding AG
17.28
-2.70%
DB0.F Q32 Bio Inc.
1.4100
-5.66%
APGE Apogee Therapeutics, Inc.
39.85
+0.28%
ANTH Anthera Pharmaceuticals, Inc.
0.0001
0.00%
ADXS Ayala Pharmaceuticals, Inc.
0.0300
0.00%
IKT Inhibikase Therapeutics, Inc.
2.1200
-4.93%
VINC Vincerx Pharma, Inc.
0.0592
+18.40%
FBLG FibroBiologics, Inc.
0.8315
-1.01%